API
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent in fringement and its liability is at buyer's risk.
PRODUCT | CAS No | Available Standard | Available Documents |
Bendamustine Hcl | 3543-75-7;97832-05-8 | In-House | WC/DMF |
Brivaracetam | 357336-20-0 | In-House | Local GMP/DMF |
Dexketoprofen Trometamol | 156604-79-4 | In-House | Local GMP/WC/DMF |
Dexketoprofen Base | 22161-81-5 | In-House | Local GMP/WC/DMF |
Dydrogesterone | 152-62-5 | USP/EP | / |
Dicloxacillin Sodium | 13412-64-1 | USP/EP/BP | GMP/DMF |
Diflucortolone Valerate | 59198-70-8 | BP | WC/DMF |
Dolutegravir Sodium | 1051375-16-6 | In-House | DMF |
Docetaxel Anhydrous | 114977-28-5 | USP/EP | GMP/WC/DMF/CEP |
Docetaxel Trihydrate | 148408-66-6 | USP/EP | GMP/WC/DMF |
Elagolix | 1257044-40-8 | In-House | / |
Empagliflozin | 864070-44-0 | In-House | WC/Local GMP/DMF |
Erdosteine | 84611-23-4;105426-14-0 | USP/EP | GMP/DMF |
Ertapenem Sodium | 153773-82-1 | USP | GMP/DMF |
Edoxaban | 480449-70-5 | In-House | / |
Fingolimod Hcl | 162359-56-0 | In-House | Local GMP/DMF |
Linagliptin | 668270-12-0 | In-House | Local GMP/WC/DMF |
Mirabegrone | 223673-61-8 | In-House | WC/Local GMP/DMF |
Mesalazine | 89-57-6 | USP/EP | WC/DMF/CEP |
Meropenem with Sodium Carbonate | 96036-03-2 | USP | GMP/DMF |
Moxifloxacin Hcl | 186826-86-8 | USP/EP | WC/GMP/DMF |
Vinblastine Sulfate | 143-67-9 | USP | WC/DMF |
Vincristine Sulfate | 2068-78-2 | USP | WC/DMF |
Vinorelbine Tartrate | 125317-39-7 | USP/EP | GMP/WC/DMF/CEP |
Paclitaxel | 33069-62-4 | USP/EP | GMP/WC/DMF/CEP |
Pregabaline | 148553-50-8 | USP/EP | Local GMP/WC/DMF/CEP |
Pamalidomide | 19171-19-8 | In-House | Local GMP/DMF |
Rosuvastatin Calcium | 147098-20-2 | USP/EP | Local GMP/WC/DMF/CEP |
Sacubitril Sodium | 274693-27-5 | In-House | WC/Local GMP/DMF |
Sugammadex Sodium | 343306-79-6 | In-House | Local GMP/DMF |
Tenofovir Disoproxil Fumarate | 202138-50-9 | USP | GMP/DMF |
Tenofovir Alafenamide Hemifumarate | 1392275-56-7 | In-House | Local GMP/DMF |
Ticagrelor | 274693-27-5 | EP | WC/Local GMP/DMF |
Tofacitinib Citrate | 540737-29-9 | In-House | Local GMP/DMF |
|
|
|
|